Nuvectis Pharma (NVCT) Non-Current Assets (2021)

Nuvectis Pharma (NVCT) reported Non-Current Assets of $824000.0 for Q4 2021.

Nuvectis Pharma (NVCT) Non-Current Assets (2021) Analysis & Trends

Nuvectis Pharma (NVCT) has 1 years of Non-Current Assets data on file, last reported at $824000.0 in Q4 2021.

For the quarter ending Q4 2021, Non-Current Assets changed N/A year-over-year to $824000.0; the trailing twelve-month figure through Sep 2022 stood at $824000.0 (changed N/A YoY), and the FY2021 full-year result was $824000.0, changed N/A from the prior year.
Non-Current Assets held at $824000.0 in Q4 2021.
In the past five years, Non-Current Assets ranged from a high of $824000.0 in Q4 2021 to a low of $824000.0 in Q4 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	21.65 Mn
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	5.83 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	30.30 Mn
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	1.95 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	14.75 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.66 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-	289.41 Mn
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	285.82 Mn
10	Nuvectis Pharma	453.54 Mn	453.54 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2021	824,000.00